ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Budapest, Budapest, HUN:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Budapest, Hungary and 59 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Budapest, Hungary and 187 other locations

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilint...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Cagrilintide
Drug: Placebo (matched to Cagrilintide)

Phase 3

Novo Nordisk
Novo Nordisk

Komárom, Hungary and 66 other locations

New

The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective a...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: UBT251
Drug: Semaglutide Placebo

Phase 2

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 68 other locations

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM an...

Begins enrollment this month
Type 2 Diabetes Mellitus
Drug: Elecoglipron
Drug: Semaglutide

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 157 other locations

effective for treating people who have excess body weight and type 2 diabetes. There are 2 study treatments in this study taken as injection...

Enrolling
Diabetes Mellitus
Overweight
Drug: NNC0487-0111
Drug: Placebo (matched to NNC0487-0111)

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 72 other locations

Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

Phase 2

Roche
Roche

Budapest, Hungary and 50 other locations

with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone...

Begins enrollment this month
Type 2 Diabetes Mellitus
Drug: Dapagliflozin
Drug: Dapagliflozin-matched placebo

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 137 other locations

elecoglipron alone and dapagliflozin alone, in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management al...

Begins enrollment this month
Type 2 Diabetes Mellitus
Drug: Dapagliflozin-matched placebo
Drug: Elecoglipron

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 177 other locations

effective for treating people who have excess body weight and type 2 diabetes. Participant will receive 2 injections every week: an active m...

Not yet enrolling
Diabetes Mellitus, Type 2
Overweight
Drug: Placebo (matched to semaglutide)
Drug: NNC0487-0111

Phase 3

Novo Nordisk
Novo Nordisk

Komárom, Komárom-Esztergom, Hungary and 119 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems